Cue Biopharma Inc (CUE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cue Biopharma Inc-Aktie (CUE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.71% 1.717	1.821	2.10	1.382	0.187
Operating Expenses	8.10% 14.38	15.65	13.52	14.90	13.57
Interest Income/Expense	104.60% 0.033	-0.718	0.254	0.35	0.3304
Benefits Costs and Expenses	7.81% 14.06	15.26	-	-	13.30
Costs And Expenses	7.81% 14.06	15.26	13.52	14.90	13.30
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Depreciation and Amortization	12.39% 0.099	0.113	0.13	0.136	0.177
Operating Income/Loss	8.42% -12.67	-13.83	-11.42	-13.52	-13.38
Net Interest Income/Expense	52.47% -0.241	-0.507	-0.286	-0.232	-0.37
Nonoperating Income/Loss	19.35% 0.321	0.398	0.414	0.332	0.271
Income/Loss From Continuing Operations Before Tax	8.09% -12.35	-13.43	2.10	1.382	-13.11
Income/Loss From Continuing Operations After Tax	8.09% -12.35	-13.43	-11.01	-13.19	-13.11
Net Income/Loss	8.09% -12.35	-13.43	-11.01	-13.19	-13.11
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	10,191% 49.47	0.4807	46.36	44.80	44.65
Diluted Average Shares	10,191% 49.47	0.4807	46.36	44.80	44.65
Basic Earnings Per Share	13.79% -0.25	-0.29	-0.24	-0.29	-0.29
Diluted Earnings Per Share	13.79% -0.25	-0.29	-0.24	-0.29	-0.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%